Moleculin Biotech Inc Live Share Price Today, Share Analysis and Chart

Name: Moleculin Biotech Inc: Is Infosys Ltd. worth buying?
Item: Moleculin Biotech Inc
Rating: 0.48266675
Author: Trendlyne DVM scores

about

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline ...

0.60 0.05 (9.09%)

87.26% Fall from 52W High

2.4M

XNAS Volume

High vol.+gain this week

XNAS 14 Jul, 2025 11:37 AM (EDT)

Not Eligible

Expensive Valuation

0.2 / 100

Technically Bearish

19.1 / 100

No estimates available

Moleculin Biotech Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Moleculin Biotech Inc Live Share Price Today, Share Analysis and Chart

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline ...

87.26% Fall from 52W High

High vol.+gain this week

SWOT Analysis

Moleculin Biotech Inc Live Price Chart